Dai-ichi Life Insurance Company’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,755
| Closed | -$843K | – | 488 |
|
|
2026
Q1 | $843K | Sell |
3,755
-261
| -6% | -$65K | 0.02% | 372 |
|
|
2025
Q4 | $967K | Hold |
4,016
| – | – | 0.02% | 379 |
|
|
2025
Q3 | $1.1M | Buy |
4,016
+3,000
| +295% | +$819K | 0.03% | 348 |
|
|
2025
Q2 | $262K | Hold |
1,016
| – | – | 0.01% | 469 |
|
|
2025
Q1 | $227K | Hold |
1,016
| – | – | 0.01% | 477 |
|
|
2024
Q4 | $232K | Hold |
1,016
| – | – | 0.01% | 474 |
|
|
2024
Q3 | $248K | Sell |
1,016
-228
| -18% | -$50.9K | 0.01% | 476 |
|
|
2024
Q2 | $238K | Sell |
1,244
-19,800
| -94% | -$4.02M | 0.01% | 442 |
|
|
2024
Q1 | $4.17M | Sell |
21,044
-24,400
| -54% | -$4.47M | 0.09% | 202 |
|
|
2023
Q4 | $7.82M | Buy |
45,444
+31,510
| +226% | +$4.84M | 0.16% | 124 |
|
|
2023
Q3 | $2.06M | Sell |
13,934
-9,000
| -39% | -$1.63M | 0.05% | 280 |
|
|
2023
Q2 | $5.01M | Sell |
22,934
-16,800
| -42% | -$3.74M | 0.1% | 171 |
|
|
2023
Q1 | $8.7M | Buy |
39,734
+3,502
| +10% | +$760K | 0.19% | 103 |
|
|
2022
Q4 | $7.54M | Buy |
36,232
+21,490
| +146% | +$4.72M | 0.17% | 117 |
|
|
2022
Q3 | $3.22M | Buy |
14,742
+3,000
| +26% | +$683K | 0.08% | 212 |
|
|
2022
Q2 | $2.46M | Sell |
11,742
-10,000
| -46% | -$2.13M | 0.05% | 257 |
|
|
2022
Q1 | $5.27M | Hold |
21,742
| – | – | 0.08% | 203 |
|
|
2021
Q4 | $5.66M | Hold |
21,742
| – | – | 0.07% | 205 |
|
|
2021
Q3 | $5.73M | Buy |
21,742
+3,278
| +18% | +$896K | 0.07% | 197 |
|
|
2021
Q2 | $4.55M | Hold |
18,464
| – | – | 0.06% | 227 |
|
|
2021
Q1 | $3.58M | Hold |
18,464
| – | – | 0.05% | 252 |
|
|
2020
Q4 | $3.92M | Buy |
18,464
+7,800
| +73% | +$1.56M | 0.06% | 228 |
|
|
2020
Q3 | $1.83M | Sell |
10,664
-3,000
| -22% | -$554K | 0.03% | 320 |
|
|
2020
Q2 | $2.62M | Sell |
13,664
-231
| -2% | -$37.8K | 0.06% | 240 |
|
|
2020
Q1 | $2.05M | Hold |
13,895
| – | – | 0.08% | 245 |
|
|
2019
Q4 | $2.15M | Sell |
13,895
-155
| -1% | -$22.3K | 0.05% | 320 |
|
|
2019
Q3 | $1.9M | Hold |
14,050
| – | – | 0.05% | 332 |
|
|
2019
Q2 | $1.72M | Sell |
14,050
-11,941
| -46% | -$1.32M | 0.04% | 352 |
|
|
2019
Q1 | $2.7M | Hold |
25,991
| – | – | 0.07% | 284 |
|
|
2018
Q4 | $2.96M | Buy |
25,991
+12,000
| +86% | +$1.29M | 0.08% | 245 |
|
|
2018
Q3 | $1.61M | Buy |
13,991
+11,941
| +582% | +$1.31M | 0.03% | 360 |
|
|
2018
Q2 | $212K | Hold |
2,050
| – | – | 0.01% | 501 |
|
|
2018
Q1 | $202K | Buy |
+2,050
| New | +$194K | ﹤0.01% | 510 |
|
|
2017
Q2 | – | Sell |
-2,842
| Closed | -$205K | – | 541 |
|
|
2017
Q1 | $205K | Buy |
+2,842
| New | +$196K | 0.01% | 539 |
|
Other funds holding RMD
Dai-ichi Life Insurance Company's RMD Position: Q2 2026 in Review
Dai-ichi Life Insurance Company sold out of ResMed (RMD) in Q2 2026, closing a stake of 3,755 shares — an estimated $843K sold.
Dai-ichi Life Insurance Company first reported a position in RMD in Q1 2017 and held it in 34 quarters. The position peaked at $8.7M in Q1 2023. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Dai-ichi Life Insurance Company reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- Dai-ichi Life Insurance Company sold 3,755 ResMed shares in Q2 2026, an estimated $843K.
- Dai-ichi Life Insurance Company first reported a position in ResMed in Q1 2017 and held it in 34 quarters.
- Dai-ichi Life Insurance Company's ResMed position peaked at $8.7M in Q1 2023.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.